CRL vs GENK · rev $2.00B vs rev $212.5M
Charles River Laboratories (CRL) versus GEN Restaurant Group, Inc. Class A Common Stock (GENK) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
GEN Restaurant Group, Inc. Class A Common Stock (GENK) is a restaurants company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported GENK revenue for 2025-12-31 was $212.5M. Net income was -$3.0M. Revenue was up 2.0% from 2024-12-31 to 2025-12-31. GENK currently screens at market cap $63.6M.
CRL currently screens at market cap $7.78B. GENK currently screens at market cap $63.6M.
Not investment advice. Open the CRL and GENK stock pages for the full models.
Not investment advice.